These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28063955)

  • 1. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients.
    Blixt T; Gradel KO; Homann C; Seidelin JB; Schønning K; Lester A; Houlind J; Stangerup M; Gottlieb M; Knudsen JD
    Gastroenterology; 2017 Apr; 152(5):1031-1041.e2. PubMed ID: 28063955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.
    Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmissibility of Clostridium difficile Without Contact Isolation: Results From a Prospective Observational Study With 451 Patients.
    Widmer AF; Frei R; Erb S; Stranden A; Kuijper EJ; Knetsch CW; Tschudin-Sutter S
    Clin Infect Dis; 2017 Feb; 64(4):393-400. PubMed ID: 28172613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation.
    Lanzas C; Dubberke ER
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):1043-50. PubMed ID: 25026622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.
    McFarland LV; Surawicz CM; Stamm WE
    J Infect Dis; 1990 Sep; 162(3):678-84. PubMed ID: 2387993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction.
    Mutters R; Nonnenmacher C; Susin C; Albrecht U; Kropatsch R; Schumacher S
    J Hosp Infect; 2009 Jan; 71(1):43-8. PubMed ID: 19041162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and Isolation of Clostridium difficile Asymptomatic Carriers During Clostridium difficile Infection Outbreaks: An Exploratory Study.
    Paquet-Bolduc B; Gervais P; Roussy JF; Trottier S; Oughton M; Brukner I; Longtin J; Loo VG; Dascal A; Longtin Y
    Clin Infect Dis; 2018 Nov; 67(11):1781-1783. PubMed ID: 29771298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
    Brown K; Valenta K; Fisman D; Simor A; Daneman N
    JAMA Intern Med; 2015 Apr; 175(4):626-33. PubMed ID: 25705994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
    Durham DP; Olsen MA; Dubberke ER; Galvani AP; Townsend JP
    Emerg Infect Dis; 2016 Apr; 22(4):608-16. PubMed ID: 26982504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey.
    Mainardi JL; Lacassin F; Guilloy Y; Goldstein FW; Leport C; Acar JF; Vildé JL
    J Infect; 1998 Sep; 37(2):108-11. PubMed ID: 9821082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization of Toxigenic
    Mi H; Bao R; Xiao Y; Cui Y; Sun W; Shen Y; Shi Q; Chen X; Lin J; Hu B; Gao X
    Front Cell Infect Microbiol; 2020; 10():12. PubMed ID: 32083021
    [No Abstract]   [Full Text] [Related]  

  • 19. Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention Efforts.
    McDonald LC; Diekema DJ
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of
    Baron SW; Ostrowsky BE; Nori P; Drory DY; Levi MH; Szymczak WA; Rinke ML; Southern WN
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):149-153. PubMed ID: 31822302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.